Identification of Biktarvy:
No description |
Search images on Google Product Monograph
Active Ingredients:
- bictegravir (bictegravir sodium), 50 MG
- emtricitabine, 200 MG
- tenofovir alafenamide (tenofovir alafenamide hemifumarate), 25 MG
DIN: 02478579
Dosage Form(s): TABLET
Route(s) of Administration: ORAL
Schedule: Prescription
Company: GILEAD SCIENCES CANADA INC
ATC:
- J05 - ANTIVIRALS FOR SYSTEMIC USE (ATC, WHO, Wiki)
- J05A - DIRECT ACTING ANTIVIRALS (ATC, WHO)
- J05AR - Antivirals for treatment of HIV infections, combinations (ATC, WHO)
- J05AR20 - EMTRICITABINE, TENOFOVIR ALAFENAMIDE AND BICTEGRAVIR (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 30